Clinical trial · Observational
Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period
Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period: a Feasibility Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Unrecognised changes in patients' vital signs after surgery can result in preventable complications. Current standard practice includes routine monitoring of patient vital signs up until hospital discharge. Upon discharge from hospital, all forms of routine vital sign monitoring ceases. The availability and use of wearable technology in healthcare is increasing rapidly. The role of wearable technology in the remote monitoring of patients at high-risk of post-operative complications and hospital readmission after discharge from hospital is unclear. This pilot study is aimed to assess the feasibility of using wearable technology in patients recovering from major intracavity surgery after hospital discharge in the Irish healthcare setting.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adult ALL | Adult Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
| Anesthesia | — | UNRESOLVED | — |
| Postoperative Complications | — | UNRESOLVED | — |
| Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| LifeSignals 1AX Biosensor | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Adult patients being discharged from hospital following intra-abdominal or pelvic surgery
- description
- Patient compliance with wearable biosensor monitoring after major intracavity surgery. The remote monitoring is made up of a wearable biosensor and a data-enabled relay device which will detect vital sign observations (ECG, heart rate, temperature and respiratory rate) and a health status assessment questionnaire.
- interventionNames
- Device: LifeSignals 1AX Biosensor
Primary outcomes (1)
- measure
- Compliance with wearable technology
- timeFrame
- 30-days
- description
- Assess compliance with remote monitoring in the first 30-days after hospital discharge following intra-abdominal or pelvic surgery. Compliance will be defined as wearing the biosensor for at least 20 hours per day.
Secondary outcomes (5)
- measure
- Unplanned hospital admission or GP visits
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Over 18 years of age * Scheduled to undergo or recently undergone major intra-cavity abdominal surgery * Able to give informed written consent to participate Exclusion Criteria: * Deemed unfit for surgery * Unable or unwilling to comply with remote monitoring for any reason * Unable or unwilling to fill in a questionnaire in English
References
Publications (0)
Data not yet available